Anti-leukemic effects of all-trans retinoic acid in combination with Daratumumab in acute myeloid leukemia-Reference-Cited by-同舟云学术

Anti-leukemic effects of all-trans retinoic acid in combination with Daratumumab in acute myeloid leukemia

Published:2018-06-02 Issue:8 Volume:30 Page:375-383
ISSN:0953-8178
Container-title:International Immunology
language:en
Short-container-title:

Author:

Buteyn Nathaniel J¹,Fatehchand Kavin²,Santhanam Ramasamy³,Fang Huiqing³,Dettorre Gino M³,Gautam Shalini³,Harrington Bonnie K⁴,Henderson Sally E⁴,Merchand-Reyes Giovanna¹,Mo Xiaokui⁵,Benson Don M³,Carson William E³,Vasu Sumithira³,Byrd John C³,Butchar Jonathan P³,Tridandapani Susheela³

Affiliation:

1. Molecular, Cellular and Developmental Biology Program, The Ohio State University, Columbus, OH, USA

2. Medical Scientist Training Program, The Ohio State University, Columbus, OH, USA

3. Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

4. Department of Veterinary Biosciences, The Ohio State University, Columbus, OH, USA

5. Center for Biostatistics, The Ohio State University, Columbus, OH, USA

Funder

National Institutes of Health

NIH

Ohio State University Comprehensive Cancer Center

Ohio State University Comprehensive Cancer Center Leukemia Research Program Seed Award

Publisher

Oxford University Press (OUP)

Subject

Immunology,General Medicine,Immunology and Allergy

Link

http://academic.oup.com/intimm/article-pdf/30/8/375/25209086/dxy040.pdf

Reference36 articles.

1. Emerging therapeutic drugs for AML;Stein;Blood,2016

2. AML in 2016: where we are now;Rowe;Best Pract. Res. Clin. Haematol,2016

3. Current challenges in clinical development of ‘targeted therapies’: the case of acute myeloid leukemia;Estey;Blood,2015

4. An update of current treatments for adult acute myeloid leukemia;Dombret;Blood,2016

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Successful therapy with azacitidine for acute myeloid leukemia with NUP98::RARG resembling acute promyelocytic leukemia;Frontiers in Oncology;2024-09-04

2. Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia;JCI Insight;2024-04-22

3. FLT‐3 mutation maybe an inferior predictor of daratumumab therapy in acute myeloid leukemia patients relapsed after allogeneic stem cell transplantation;International Journal of Laboratory Hematology;2024-04-10

4. Exogenous Antigen Upregulation Empowers Antibody Targeted Nanochemotherapy of Leukemia;Advanced Materials;2023-06-30

5. Exogenous CD38 upregulation enables high-efficacy dually cascade targeted molecular therapy of leukemia;Nano Today;2023-06